164 related articles for article (PubMed ID: 16247081)
1. RAS pathway activation and an oncogenic RAS mutation in sporadic pilocytic astrocytoma.
Sharma MK; Zehnbauer BA; Watson MA; Gutmann DH
Neurology; 2005 Oct; 65(8):1335-6. PubMed ID: 16247081
[No Abstract] [Full Text] [Related]
2. Further evidence for a somatic KRAS mutation in a pilocytic astrocytoma.
Janzarik WG; Kratz CP; Loges NT; Olbrich H; Klein C; Schäfer T; Scheurlen W; Roggendorf W; Weiller C; Niemeyer C; Korinthenberg R; Pfister S; Omran H
Neuropediatrics; 2007 Apr; 38(2):61-3. PubMed ID: 17712732
[TBL] [Abstract][Full Text] [Related]
3. Ras oncogene mutations in childhood brain tumors.
Maltzman TH; Mueller BA; Schroeder J; Rutledge JC; Patterson K; Preston-Martin S; Faustman EM
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):239-43. PubMed ID: 9107428
[TBL] [Abstract][Full Text] [Related]
4. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice.
Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D
Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344
[TBL] [Abstract][Full Text] [Related]
5. Genome-wide single-nucleotide polymorphism analysis in juvenile myelomonocytic leukemia identifies uniparental disomy surrounding the NF1 locus in cases associated with neurofibromatosis but not in cases with mutant RAS or PTPN11.
Flotho C; Steinemann D; Mullighan CG; Neale G; Mayer K; Kratz CP; Schlegelberger B; Downing JR; Niemeyer CM
Oncogene; 2007 Aug; 26(39):5816-21. PubMed ID: 17353900
[TBL] [Abstract][Full Text] [Related]
6. Parallel signaling pathways in endothelin-1-induced proliferation of U373MG astrocytoma cells.
He S; Dibas A; Yorio T; Prasanna G
Exp Biol Med (Maywood); 2007 Mar; 232(3):370-84. PubMed ID: 17327470
[TBL] [Abstract][Full Text] [Related]
7. Acquisition of JAK2, PTPN11, and RAS mutations during disease progression in primary myelodysplastic syndrome.
Chen CY; Lin LI; Tang JL; Tsay W; Chang HH; Yeh YC; Huang CF; Chiou RJ; Yao M; Ko BS; Chen YC; Lin KH; Lin DT; Tien HF
Leukemia; 2006 Jun; 20(6):1155-8. PubMed ID: 16598312
[No Abstract] [Full Text] [Related]
8. Akt-dependent proapoptotic effects of dietary restriction on late-stage management of a phosphatase and tensin homologue/tuberous sclerosis complex 2-deficient mouse astrocytoma.
Marsh J; Mukherjee P; Seyfried TN
Clin Cancer Res; 2008 Dec; 14(23):7751-62. PubMed ID: 19047102
[TBL] [Abstract][Full Text] [Related]
9. [Blood oncogene detection in patients with colorectal carcinoma].
Raedle J; Brieger A; Zeuzem S
Z Gastroenterol; 1998 Mar; 36(3):257-9. PubMed ID: 9577911
[No Abstract] [Full Text] [Related]
10. Pilocytic astrocytoma: a disease with evolving molecular heterogeneity.
Sadighi Z; Slopis J
J Child Neurol; 2013 May; 28(5):625-32. PubMed ID: 23439714
[TBL] [Abstract][Full Text] [Related]
11. CTNNB1 (beta-catenin) mutation is rare in brain tumours but involved as a sporadic event in a brain metastasis.
Lee CI; Hsu MY; Chou CH; Wang C; Lo YS; Loh JK; Howng SL; Hong YR
Acta Neurochir (Wien); 2009 Sep; 151(9):1107-11. PubMed ID: 19582367
[TBL] [Abstract][Full Text] [Related]
12. Expression of Rac3 in human brain tumors.
Hwang SL; Chang JH; Cheng TS; Sy WD; Lieu AS; Lin CL; Lee KS; Howng SL; Hong YR
J Clin Neurosci; 2005 Jun; 12(5):571-4. PubMed ID: 15993075
[TBL] [Abstract][Full Text] [Related]
13. Paired overexpression of ErbB3 and Sox10 in pilocytic astrocytoma.
Addo-Yobo SO; Straessle J; Anwar A; Donson AM; Kleinschmidt-Demasters BK; Foreman NK
J Neuropathol Exp Neurol; 2006 Aug; 65(8):769-75. PubMed ID: 16896310
[TBL] [Abstract][Full Text] [Related]
14. Hyperactive Ras in developmental disorders and cancer.
Schubbert S; Shannon K; Bollag G
Nat Rev Cancer; 2007 Apr; 7(4):295-308. PubMed ID: 17384584
[TBL] [Abstract][Full Text] [Related]
15. Loss of neurofibromin is associated with activation of RAS/MAPK and PI3-K/AKT signaling in a neurofibromatosis 1 astrocytoma.
Lau N; Feldkamp MM; Roncari L; Loehr AH; Shannon P; Gutmann DH; Guha A
J Neuropathol Exp Neurol; 2000 Sep; 59(9):759-67. PubMed ID: 11005256
[TBL] [Abstract][Full Text] [Related]
16. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
Lee ST; Ki CS; Lee HJ
Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
[TBL] [Abstract][Full Text] [Related]
17. Second hit mutations in the RTK/RAS signaling pathway in acute myeloid leukemia with inv(16).
Valk PJ; Bowen DT; Frew ME; Goodeve AC; Löwenberg B; Reilly JT
Haematologica; 2004 Jan; 89(1):106. PubMed ID: 14754614
[No Abstract] [Full Text] [Related]
18. Differences in the prevalence of PTPN11 mutations in FAB M5 paediatric acute myeloid leukaemia.
Goemans BF; Zwaan CM; Martinelli S; Harrell P; de Lange D; Carta C; Reinhardt D; Hählen K; Creutzig U; Tartaglia M; Heinrich MC; Kaspers GJ
Br J Haematol; 2005 Sep; 130(5):801-3. PubMed ID: 16115145
[No Abstract] [Full Text] [Related]
19. Reduction in the requirement of oncogenic Ras signaling to activation of PI3K/AKT pathway during tumor maintenance.
Lim KH; Counter CM
Cancer Cell; 2005 Nov; 8(5):381-92. PubMed ID: 16286246
[TBL] [Abstract][Full Text] [Related]
20. Pilocytic astrocytoma in a child with Noonan syndrome.
Schuettpelz LG; McDonald S; Whitesell K; Desruisseau DM; Grange DK; Gurnett CA; Wilson DB
Pediatr Blood Cancer; 2009 Dec; 53(6):1147-9. PubMed ID: 19621452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]